Jiahui International Hospital and Brigham and Women#s Hospital to Co-Develop Women#s Health Center of Excellence in Shanghai

Food and Healthcare Press Releases Monday August 10, 2015 18:23
BOSTON--10 Aug--PRNewswire/InfoQuest
Memorandum of Understanding signed, which extends the long-term, collaborative partnership between Jiahui International Hospital and Partners HealthCare.

Today,   Jiahui International Hospital (JIH), Partners HealthCare International (R)(PHI) and   Brigham and Women's Hospital (BWH) announced the extension of a long-term collaborative partnership between JIH and PHI to include the development of a women's health center of excellence at JIH. In July, JIH, BWH and PHI signed a Memorandum of Understanding (MOU) that initiated discussions about a women's health affiliation, which includes the development of obstetric, gynecology, and in vitro fertilization programs, as well as a neonatal ICU and integrated women's health. JIH envisions a full complement of integrated services focused on the health of the whole woman at the new women's health center of excellence.

Photo - http://photos.prnewswire.com/prnh/20150805/255965
Logo - http://photos.prnewswire.com/prnh/20150805/256364LOGO

BWH, a founding member of Partners HealthCare, has   one of the most advanced women's health centers in the world, which is committed to the discovery, dissemination, and integration of knowledge on women's health and sex and gender-based differences; applying this knowledge to the delivery of care; and developing the next generation of clinicians and scientists in women's health research and clinical care.

"We aim to redefine and redesign health care for women in China, offering a full range of care that tailors to their needs at different stages of life," said Feng Ge, Chief Executive Officer of Jiahui International Hospital. "Chinese women today value convenience, clinical quality, and a patient-centric experience. Many are looking for a high-caliber healthcare provider partner who not only empowers them to live a healthy lifestyle and seek preventive care, but someone who is also capable of handling both normal and complex cases that require the close collaboration of multiple medical subspecialties."

"As global citizens, we are committed to forging meaningful partnerships that allow us to share our clinical, scientific and teaching expertise for the benefit of people around the world," said Elizabeth G. Nabel , MD, president of Brigham and Women's Healthcare. "We look forward to working with Jiahui International Hospital to improve the health and well-being of women in China."

BWH's approach to women's health is multidisciplinary, organized around all of the resources that a woman may require for a specific condition, from diagnosis to coordination of care and accessibility of information. In addition to the traditional fields of obstetrics, gynecology, and breast and gynecological cancers, the   Women's Health Center of Excellence at BWH is unique in its integration with other specialties, including collaborative clinical, research and educational programs in cardiology, neurology, bone and joint diseases, lung cancer and pulmonary disease, and mental health.

"We know that there are differences between men and women in the risk, prevalence and manifestation of many different diseases, and that the response to treatment and the outcomes also differ by sex. This is especially true in some of the most prevalent diseases in women such as cardiovascular disease, lung cancer, depression and Alzheimer's disease," said Paula A. Johnson, MD, Executive Director of the   Mary Horrigan Connors Center for Women's Health and Gender Biology and Professor of Medicine at Harvard Medical School. "At BWH, we are committed to building local and global awareness of issues related to women's health and gender biology, to deepening our understanding of how disease differs in women, and to delivering high-quality, patient-centered care to women across their lifetime."

"We are excited to have the opportunity to work with Brigham and Women's Hospital, a world recognized leader and innovator in women's health. The expertise available at Brigham and Women's will help us develop a program that will not only elevate, but transform the level of health care services that women are currently offered in China," said Ge.

"This marks yet another important milestone in our 5-year partnership with JIH. In addition to this newest development, our efforts in Shanghai have also included important contributions from other Partners member hospitals, including, Massachusetts General Hospital, Newton-Wellesley Hospital, and North Shore Medical Center," said Dr. Gilbert H. Mudge, President and CEO of PHI.

The proposed Women's Health Center of Excellence is the second such collaboration with member institutions of Partners HealthCare. Last October, Massachusetts General Hospital Cancer Center (MGHCC) signed a MOU with JIH and PHI to co-develop a center of excellence in breast cancer, tailoring MGHCC's patient-focused multidisciplinary approach to address the needs of Chinese breast cancer patients and their families.

About Jiahui International Hospital

Jiahui International Hospital (JIH) is a foreign-majority-owned for-profit general hospital being developed in Shanghai. It was approved by China's Ministry of Health ("MOH") and Shanghai Municipal Government in April 2011 and has China's first international general hospital license granted by the MOH. The hospital is conveniently located within the city center of Shanghai in Xuhui District with approved tertiary care capacity of 500 licensed beds.

JIH will be an innovative model of health care centered on family, community and a stronger connection between patients and caregivers. From design to operation, JIH aims to employ the best practices to become an internationally recognized leading medical institution in China, providing high-quality, patient-centered, integrated healthcare services, as well as professional training and clinical research.

To learn more about our hospital, please visit www.jiahui.com.
About Partners HealthCare International

Partners HealthCare International (PHI) is the global arm of Partners HealthCare, one of the leading not-for-profit health care systems in the U.S. Founded in 1997, PHI is dedicated to advancing the Partners HealthCare mission worldwide through collaborations and partnerships designed to expand a global client's capacity to deliver high quality health care. Partners was founded in 1994 by Brigham and Women's Hospital and Massachusetts General Hospital, the two oldest and largest teaching hospitals of Harvard Medical School, and includes community and specialty hospitals, a ma care organization, a physician network, community health centers, home care and other health-related entities. Partners' five top-ranked hospitals comprise part of the health care system, and all are recognized by the 2014 - 2015 U.S. News and World Report. To learn more about PHI and how we are extending the capabilities of healthcare systems in China, India, Japan, the Middle East, as well as our commitment to international markets beyond, please visit www.partners.org/international.

About Brigham and Women's Hospital

Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare . BWH has more than 4.2 million annual patient visits, nearly 46,000 inpatient stays and employs nearly 16,000 people. The Brigham's medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care,   quality improvement and patient safety initiatives , and a dedication to research , innovation ,   community engagement and   educating and training the next generation of health care professionals. Through investigation and discovery conducted at its   Brigham Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, more than 1,000 physician-investigators and renowned biomedical scientists and faculty supported by nearly $600 million in funding. For the last 25 years, BWH ranked second in research funding from the National Institutes of Health (NIH) among independent hospitals. BWH continually pushes the boundaries of medicine, including building on its legacy in transplantation by performing a partial face transplant in 2009 and the nation's   first full face transplant in 2011. BWH is also home to major landmark epidemiologic population studies, including the Nurses ' and Physicians ' Health Studies and the   Women's Health Initiative as well as the TIMI Study Group, one of the premier cardiovascular clinical trials groups. For more information, resources and to follow us on social media, please visit BWH's online newsroom .

For interviews with Dr. Paula Johnson, and/or Dr. Gilbert Mudge, please contact:
Dorian Zhou, Jiahui International Hospital (Shanghai, China) dorian.zhou@jiahui.com;
Stephanie Adams, Partners HealthCare International, sadams9@partners.org, +1-617-535-647 (U.S.)
Lori J. Schroth, Brigham and Women's Hospital, ljschroth@partners.org

Latest Press Release

Biotech Conagen Acquires Production Platform of Therapeutic Proteins

Conagen, a vertically integrated synthetic biology company located in Boston's biotech corridor, announced today that it has acquired a fermentation-based technology for the production of therapeutically useful glycoproteins. The acquisition includes...

Pneuma Respiratory, Inc. Announces New Chairman of the Board

Pneuma Respiratory, Inc. announced that Board member Jay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman, Walt Robb, will remain a member of the Board of Directors. Jay Morgan served as VP Global Innovation and...

Global market of dietary supplement is welcoming a rising star GLYMATE

Glymate(TM), a newly founded nutraceutical company in Southern California. Its proprietary sugar balance dietary supplement was officially announced in the United States in June 2019, marking the official launch of the global marketing of this product,...

Xinhua Silk Road: Tasly remains China#s 2019 National Tech Innovation Demonstration Enterprise

Tasly Holding Group, one of China's leading pharmaceuticals companies, has recently passed through the country's review of National Technology Innovation Demonstration Enterprise in 2019, thanks to its continuous innovations made in the recent...

SweeGen#s non-GMO Reb M Stevia Leaf Sweetener Approved in Singapore

SweeGen, Inc., a nature-based sweetener company, announced the Singapore Food Agency has added SweeGen's Reb M Stevia Leaf Sweetener to the list of permitted food additives. SweeGen's Reb M is a non-caloric stevia sweetener that provides sweetness with...

Related Topics